Tissue plasminogen activator in the percutaneous drainage of splenic abscess.
Statler
John D
JD
Doherty
R Donald
RD
McLaughlin
John J
JJ
Gleason
John D
JD
McDermott
Michael P
MP
D000038:Abscess / Q000000981:diagnostic imaging / Q000382:microbiology / Q000628:therapy*; D000368:Aged; D004322:Drainage / Q000379:methods*; D004927:Escherichia coli Infections / Q000000981:diagnostic imaging / Q000382:microbiology / Q000628:therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D016908:Gram-Positive Bacterial Infections / Q000000981:diagnostic imaging / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D008297:Male; D010462:Peptostreptococcus / Q000302:isolation & purification; D013156:Splenectomy; D013158:Splenic Diseases / Q000000981:diagnostic imaging / Q000382:microbiology / Q000628:therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator